Epidemiology and clinical outcome and its main determinants among patients with inflammatory myositis

Journal Title: Health Science Monitor - Year 2022, Vol 1, Issue 2

Abstract

Background & Aims: Despite the proper understanding of pathophysiological aspects and recent development in therapeutic approaches, the outcome of patients suffering from inflammatory myositis remains unsatisfactory. In addition, there is no clinical information and a clear outlook for this disease in the community. This study aimed to evaluate the outcome of patients with inflammatory myositis (response rate to treatment) and to determine the related and predictive factors of this outcome in these patients. Materials & Methods: This historical cohort study was performed on 80 patients suffering from inflammatory myositis. By retrospectively reviewing the patient records in the hospital, basic information was extracted and through telephone calls, the outcome status of the disease, and response to treatment were assessed during follow-up and categorized as complete remission, partial remission, and no remission. Results: Within the follow-up time, 40.0% were completely treated (complete remission), 3.8% had no proper response to treatment (incomplete remission), and 13.8% did not respond to the treatment. Also, 23.8% did not refer for further treatment at least six months from the start of treatment. No death was reported within the follow-up time. We found an association between the quality of treatment response and baseline parameters, including the rate of receiving intravenous immune globulin regimen, time of symptoms onset, gender, different patterns of disease, and disease subtype. Conclusion:  A notable number of inflammatory myositis patients still do not respond to routine treatment, and we, in fact, are at the forefront of managing the disease.

Authors and Affiliations

Fatemeh Shirani,Ali Javadzadeh,abdolrezahizadiabdo rahaeebakhshizadiabdo,

Keywords

Related Articles

Cost–effectiveness analysis of jejunostomy tube feeding versus conventional nutritional method in esophageal cancer: a retrospective case control study

Background & Aims: Esophageal cancer is a research priority due to its invasive nature and poor prognosis. It ranks sixth in mortality among all forms of cancer and esophagectomy is the most conventional treatment. Jejun...

Serological and RT-PCR diagnosis approaches for COVID-19

The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, caused COVID-19, is a pandemic disease and recently become dangerous to humans in all over the world. There is no efficient medicine for treatme...

Investigating the effect of health measures and social restrictions on the COVID-19 epidemic based on the SIQR mathematical model

Background & Aims: COVID-19 pandemic is a serious concern of the World Health Organization and is considered the most important global health challenge. This study aimed to study the effect of health measures and soc...

Relationship between quality of life and disease severity of children with atopic dermatitis

Background & Aims: Atopic dermatitis (AD) has a detrimental impact on the quality of life (QoL) for both patients and their families. Our investigation delved into the correlation between the severity of the disease...

Hoteling medical consumables in the Inpatient emergency department, cost or income? A prospective observational study

Background & Aims: Estimates and available statistics indicate that, on average, 20% to 30% of the costs of a hospitalized patient are related to drugs and consumables, and on the other hand, more than 95% of treatme...

Download PDF file
  • EP ID EP723560
  • DOI http://dx.doi.org/10.52547/hsm.1.2.125
  • Views 46
  • Downloads 0

How To Cite

Fatemeh Shirani, Ali Javadzadeh, abdolrezahizadiabdo rahaeebakhshizadiabdo, (2022). Epidemiology and clinical outcome and its main determinants among patients with inflammatory myositis. Health Science Monitor, 1(2), -. https://europub.co.uk/articles/-A-723560